Green tea: An effective synergist with anticancer drugs for tertiary cancer prevention

Cancer Letters

Volumn 324, Issue 2, 2012, Pages 119-125

  Fujiki, Hirota ^a   Suganuma, Masami ^b  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

Anticancer drugs; DR 5; EGCG; GADD153; TRAIL

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTINEOPLASTIC AGENT; CATECHIN; CELECOXIB; CURCUMIN; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DOCETAXEL; DOXORUBICIN; EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; ERLOTINIB; GREEN TEA EXTRACT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; LUTEOLIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PACLITAXEL; POLYPHENOL; RALOXIFENE; SULINDAC; TRITIUM; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER TRANSPLANTATION; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GROWTH ARREST AND DNA DAMAGE INDUCIBLE 153 GENE; HEAD AND NECK CARCINOMA; HUMAN; INTESTINE TUMOR; LIVER CANCER; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; SHORT SURVEY; SQUAMOUS CELL CARCINOMA; TEA; TOXICITY TESTING; TUMOR MODEL; TUMOR XENOGRAFT;

MUS;

EID: 84864390238     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.05.012     Document Type: Review

References (59)

1. Fujiki H., Suganuma M., Imai K., Nakachi K. Green tea: cancer preventive beverage and/or drug. Cancer Lett. 2002, 188:9-13.
2. Shimizu M., Fukutomi Y., Ninomiya M., Nagura K., Kato T., Araki H., Suganuma M., Fujiki H., Moriwaki H. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol. Biomar. Prevent. 2008, 17:3020-3025.
3. Nakachi K., Matsuyama S., Miyake S., Suganuma M., Imai K. Preventive effects of drinking green tea on cancer cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2002, 13:49-54.
4. Pisters K.M.W., Newman R.A., Coldman B., Shin D.M., Khuri F.R., Hong W.K., S Glisson B., S Lee J. Phase I trial of oral green tea extract in adult patients with solid tumors. J. Clin. Oncol. 2001, 19:1830-1838.
5. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006, 66:1234-1240.
6. Tsao A.S., Liu D., Martin J., Tang X.M., Lee J.J., El-Naggar A.K., Wistuba I., Culotta K.S., Mao L., Gillenwater A., Sagesaka Y.M., Hong W.K., Papadimitrakopoulou V. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev. Res. (Phila) 2009, 2:931-941.
7. Suganuma M., Okabe S., Kai Y., Sueoka N., Sueoka E., Fujiki H. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res. 1999, 59:44-47.
8. Fujiki H., Suganuma M. Tumor promoters - microcystin-LR, nodularin and TNF-α and human cancer development. Anticancer Agents Med. Chem. 2011, 11:4-18.
9. Suganuma M., Ohkura Y., Okabe S., Fujiki H. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J. Cancer Res. Clin. Oncol. 2001, 127:69-72.
10. Masuda M., Suzui M., Weinstein I.B. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. 2001, 7:4220-4229.
11. Somers-Edgar T.J., Scandlyn M.J., Stuart E.C., Le Nedelec M.J., Valentine S.P., Rosengren R.J. The combination of epigallocatechin gallate and curcumin suppresses ERα-breast cancer cell growth in vitro and in vivo. Int. J. Cancer 2008, 122:1966-1971.
12. Liang G., Tang A., Lin X., Li L., Zhang S., Huang Z., Tang H., Li Q.Q. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int. J. Oncol. 2010, 37:111-123.
13. Milligan S.A., Burke P., Coleman D.T., Bigelow R.L., Steffan J.J., Carroll J.L., Williams B.J., Cardelli J.A. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin. Cancer Res. 2009, 15:4885-4894.
14. Fujiki H., Suganuma M. Green tea and cancer prevention. Proc. Jpn. Acad. 2002, 78:263-270.
15. Suganuma M., Saha A., Fujiki H. New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci. 2011, 102:317-323.
16. Yano T., Sugio K., Yamazaki K., Kase S., Yamaguchi M., Ondo K., Sugimachi K. Direct influence of interferon-gamma on proliferation and cell-surface antigen expression of non-small cell lung cancer cells. Lung Cancer 2000, 30:169-174.
17. Lehman T.A., Bennett W.P., Metcalf R.A., Welsh J.A., Ecker J., Modali R.V., Ullrich S., Romano J.W., Appella E., Testa J.R., Gerwin B.I., Harris C.C. p53 mutations ras mutations and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 1991, 51:4090-4096.
18. Suganuma M., Kurusu M., Suzuki K., Tasaki E., Fujiki H. Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. Int. J. Cancer 2006, 119:33-40.
19. Maytin E.V., Ubeda M., Lin J.C., Habener J.F. Stress-inducible transcription factor CHOP/GADD153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. Exp. Cell Res. 2001, 267:193-204.
20. Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990, 247:322-324.
21. Beazer-Barclay Y., Levy D.B., Moser A.R., Dove W.F., Hamilton S.R., Vogelstein B., Kinzler K.W. Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis 1996, 17:1757-1760.
22. Wang Z.Y., Hong J.Y., Huang M.T., Reuhl K.R., Conney A.H., Yang C.S. Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res. 1992, 52:1943-1947.
23. Zhang X., Zhang H., Tighiouart M., Lee J.E., Shin H.J., Khuri F.R., Yang C.S., Chen Z.G., Shin D.M. Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor. Int. J. Cancer 2008, 123:1005-1014.
24. Amin A.R.M.R., Wang D., Zhang H., Peng S., Shin H.J.C., Brandes J.C., Tighiouart M., Khuri F.R., Chen Z.G., Shin D.M. Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin. J. Biol. Chem. 2010, 285:34557-34565.
25. Chisholm K., Bray B.J., Rosengren R.J. Tamoxifen and epigallocatechin gallate (EGCG) are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer Drugs 2004, 15:889-897.
26. Shao Z.-M., Shen Z.-Z., Liu C.-H., Sartippour M.R., Go V.L., Heber D., Nguyen M. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int. J. Cancer 2002, 98:234-240.
27. Luo T., Wang J., Yin Y., Hua H., Jing J., Sun X., Li M., Zhang Y., Jiang Y. (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Res. 2010, 12:R8.
28. Ermakova S.P., Kang B.S., Choi B.Y., Choi H.S., Schuster T.F., Ma W.Y., Bode A.M., Dong Z. (-)-Epigallocatechin-3-gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res. 2006, 66:9260-9269.
29. Li J., Lee A.S. Stress induction of GRP78/BiP and its role in cancer. Curr. Mol. Med. 2006, 6:45-54.
30. Lee A.S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 2007, 67:3496-3499.
31. Stearns M.E., Wang M. Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors. Transl. Oncol. 2011, 4:147-156.
32. Adhami V.M., Malik A., Zaman N., Sarfaraz S., Siddiqui I.A., Syed D.N., Afaq F., Pasha F.S., Saleem M., Mukhtar H. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin. Cancer Res. 2007, 13:1611-1619.
33. H. Wu, Y. Xin, Y. Xiao, J. Zhao, Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts, Cancer Biother. Radiopharm. 2012 January 27 (Epub ahead of print).
34. Yoshizawa S., Horiuchi T., Suganuma M., Nishiwaki S., Yatunami J., Okabe S., Okuda T., Muto Y., Frenkel K., Troll W., Fujiki H. Penta-O-galloyl-β-D-glucose and (-)-epigallocatechin gallate (cancer preventive agents). ACS Sympos. Series 1992, 507:316-325.
35. Okabe S., Suganuma M., Hayashi M., Sueoka E., Komori A., Fujiki H. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn. J. Cancer Res. 1997, 88:639-643.
36. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998, 19:1771-1776.
37. Kuzuhara T., Tanabe A., Sei Y., Yamaguchi K., Suganuma M., Fujiki H. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins. Mol. Carcinog. 2007, 46:640-645.
38. Adachi S., Nagao T., Ingolfsson H.I., Maxfield F.R., Andersen O.S., Kopelovich L., Weinstein I.B. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res. 2007, 67:6493-6501.
39. Shimizu M., Adachi S., Masuda M., Kozawa O., Moriwaki H. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. Mol. Nutr. Food Res. 2011, 55:832-843.
40. Shimizu M., Shirakami Y., Sakai H., Yasuda Y., Kubota M., Adachi S., Tsurumi H., Hara Y., Moriwaki H. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem. Biol. Interact. 2010, 185:247-252.
41. Dong Z., Ma W., Huang C., Yang C.S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res. 1997, 57:4414-4419.
42. Umeda D., Yano S., Yamada K., Tachibana H. Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67kDa laminin receptor. J. Biol. Chem. 2008, 283:3050-3058.
43. Okabe S., Fujimoto N., Sueoka N., Suganuma M., Fujiki H. Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol. Pharm. Bull. 2001, 24:883-886.
44. Suganuma M., Takahashi A., Fujiki H. New approach to lung cancer prevention mediated through superexpression of GADD153 gene. Smoking Res. Found. Ann. Res. Rep. 2009, 2009:84-89.
45. Stuart E.C., Rosengren R.J. The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cells. Life Sci. 2008, 82:943-948.
46. Y. Hattori, T. Kojima, D. Kato, H. Matubara, M. Takigawa, N. Ishiguro, A selective estrogen receptor modulator inhibits tumor necrosis factor-α-induced apoptosis through the ERK1/2 signaling pathway in human chondrocytes, Biochem. Biophys. Res. Commun. 2012 March 29 (Epub ahead of print).
47. Yoshida T., Shiraishi T., Nakata S., Horinaka M., Wakada M., Mizutani Y., Miki T., Sakai T. Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein. Cancer Res. 2005, 65:5662-5667.
48. Shiraishi T., Yoshida T., Nakata S., Horinaka M., Wakada M., Mizutani Y., Miki T., Sakai T. Tunicamycin enhances tumor necrosis factor-related apoptosis- inducing ligand-induced apoptosis in human prostate cancer cells. Cancer Res. 2005, 65:6364-6370.
49. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.-P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., Goodwin R.G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3:673-682.
50. Kouhara J., Yoshida T., Nakata S., Horinaka M., Wakada M., Ueda Y., Yamagishi H., Sakai T. Fenretinide up-regulates UR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines. Int. J. Oncol. 2007, 30:679-687.
51. He Q., Luo X., Jin W., Huang Y., Reddy M.V., Reddy E.P., Sheikh M.S. Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP. Oncogene 2008, 27:2656-2660.
52. Ohtsuki T., Kikuchi H., Koyano T., Kowithayakorn T., Sakai T., Ishibashi M. Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis. Bioorg. Med. Chem. 2009, 17:6748-6754.
53. Nishikawa T., Nakajima T., Moriguchi M., Jo M., Sekoguchi S., Ishii M., Takashima H., Katagishi T., Kimura H., Minami M., Itoh Y., Kagawa K., Okanoue T. A green tea polyphenol epigallocatechin-3-gallate induces apoptosis of human hepatocellular carcinoma possibly through inhibition of Bcl-2 family proteins. J. Hepatol. 2006, 44:1074-1082.
54. Siddiqui I.A., Malik A., Adhami V.M., Asim M., Hafeez B.B., Sarfaraz S., Mukhtar H. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 2008, 27:2055-2063.
55. Siegelin M.D., Habel A., Gaiser T. Epigallocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma. Neurosci. Lett. 2008, 448:161-165.
56. Basu A., Haldar S. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death. Int. J. Oncol. 2009, 34:281-286.
57. Shen Q., Tian F., Jiang P., Li Y., Zhang L., Lu J., Li J. EGCG enhances TRAIL-mediated apoptosis in human melanoma A375 cell line. J. Huazhong Univ. Sci. Technol. Med. Sci. 2009, 29:771-775.
58. Fujiki H., Okuda T. (-)-Epigallocatechin gallate. Drugs Future 1992, 17:462-464.
59. Fujiki H. Green tea: health benefits as cancer preventive for humans. Chem. Rec. 2005, 5:119-132.